share_log

Canaccord Genuity Reiterates Buy on Axogen, Maintains $11 Price Target

Benzinga ·  Dec 7, 2023 23:44

Canaccord Genuity analyst Caitlin Cronin reiterates Axogen (NASDAQ:AXGN) with a Buy and maintains $11 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment